EditCo Bio
Wes Douwes is an experienced finance and operations professional with a strong background in the biotech and medical device industries. Currently serving as Vice President of Finance at EditCo Bio since April 2024, Wes previously held the position of VP of FP&A and Sales Operations at Mesa Laboratories, Inc. from April 2022 to April 2024. Prior roles include Vice President of Sales Operations and Senior Director of Finance, Sales Operations, and Business IT at Agena Bioscience, as well as an Independent Advisor, providing strategic financial guidance to clients from July 2014 to March 2015. Wes's career also features a tenure as Director of Finance & Sales Operations at Estech, Inc., and an early role as an Accountant at BrainLAB, Inc. Wes holds a degree from California Polytechnic State University-San Luis Obispo, obtained in 2000.
This person is not in the org chart
This person is not in any teams
EditCo Bio
Whatever your edit, we can make it easier with optimized, multi-guide CRISPR kits and made-to-order edited cells. We're dedicated to building a novel research toolkit to make genome engineering simpler and more efficient. EditCo's CRISPR expertise and highly automated manufacturing allows us to engineer a wide variety of cell lines with the speed, consistency, and functionality than can redefine research. Leave CRISPR to us–you focus on discoveries.